RxDoctor Payments Data

Nyree Williams

Psychiatric/Mental Health · Baltimore, MDNPI 1205407145

Payments from drug & device makers

$839in general payments, 2019–2025

Across 29 payments — averaging $28.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$287
  • AbbVie$203
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$153
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • Teva Pharmaceuticals USA, Inc.$44
  • Supernus Pharmaceuticals, Inc.$43
  • plus $63 from 2 others

What the payments were for

  • Food & beverage$839100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$839 in reported general payments places this provider in the 70th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$40,792
Medicare patients
85
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Divalproex Sodium119$6,246
Quetiapine Fumarate174$4,320
Olanzapine112$3,288
Haloperidol44$2,646
Sertraline Hcl255$2,627
Oxcarbazepine18$1,951
Gabapentin36$1,824
Risperidone182$1,692
Fluvoxamine Maleate30$1,575
Trazodone Hcl72$1,312
Benztropine Mesylate65$1,049
Buspirone Hcl22$1,013
Carbamazepine31$1,006
Duloxetine Hcl14$952
Mirtazapine73$940

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →